Pharmatest Services
Turku
About Pharmatest Services
PHARMATEST offers preclinical in vitro assays, in vivo efficacy models and ex vivo bone analysis services in the fields of oncology and skeletal diseases. We are the leading experts in combining cancer and bone biology having special expertise in bone metastases. Our cancer models cover comprehensive portfolio of xenograft, syngeneic and immuno-oncology models. We have substantial experience in performing studies with targeted radionuclide therapy in both, in vitro and in vivo studies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Funding stage: M&A
- Last round: Private Equity (Jan 2014)
- Website: pharmatest.com
- Phone: +35822784700
Industries & Categories
Biotechnology, Clinical Trials, Consulting, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/pharmatest-services-2963247 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.